Richard Markman

 Hey everyone, I wanted to put together a deep dive into something that has been floating around the biohacking and longevity circles for a while but doesn't always get the detailed attention it deserves: the intersection of mitochondrial health, cardiolipin biology, and a compound called SS-31, also known as Elamipretide. If you are into TRT, health optimization, or just want to understand why your heart is arguably the most mitochondria-dependent organ you have, this should be relevant. I'll try to break down the science without getting too lost in the weeds, but this is a complex topic so grab a coffee. Why Your Heart Cares About Mitochondria Here's a staggering fact: your heart beats roughly 100,000 times a day. It never takes a break. Not while you sleep, not while you eat, not while you're doom-scrolling Reddit at 2 AM. To keep that pump running, your cardiac muscle cells are absolutely packed with mitochondria. We're talking about 30 to 40 percent of the cell...

 Hey everyone, I wanted to put together a deep dive into something that has been floating around the biohacking and longevity circles for a while but doesn't always get the detailed attention it deserves: the intersection of mitochondrial health, cardiolipin biology, and a compound called SS-31, also known as Elamipretide. If you are into TRT, health optimization, or just want to understand why your heart is arguably the most mitochondria-dependent organ you have, this should be relevant. I'll try to break down the science without getting too lost in the weeds, but this is a complex topic so grab a coffee. Why Your Heart Cares About Mitochondria Here's a staggering fact: your heart beats roughly 100,000 times a day. It never takes a break. Not while you sleep, not while you eat, not while you're doom-scrolling Reddit at 2 AM. To keep that pump running, your cardiac muscle cells are absolutely packed with mitochondria. We're talking about 30 to 40 percent of the cell...

 I've been deep in the peptide research rabbit hole for the past few years, and I want to talk about something that doesn't get nearly enough attention in the broader biohacking and TRT communities: the amylin-calcitonin axis. Specifically, I want to break down why cagrilintide, when combined with GLP-1 analogs, represents one of the most fascinating mechanistic synergies we've seen in metabolic research to date. If you've been following the space, you know that GLP-1 receptor agonists like semaglutide and tirzepatide have dominated the conversation. And rightfully so—they work. But there's a whole other hormonal pathway that's been quietly sitting in the background, and it's finally getting the attention it deserves. Let me walk you through what's actually happening at the receptor level, why this matters, and what the research is showing. The Forgotten Hormone: What Amylin Actually Does Most people in the TRT and health optimization space know insulin....

 If you have spent any time in TRT forums, longevity communities, or the strange corner of the internet that treats peptide vials like Pokémon cards, you have seen the CJC-1295 and Ipamorelin stack mentioned approximately one million times. It is the peanut butter and jelly of growth hormone secretagogue research. The combination is everywhere. But here is the thing. Most of the discussion online is either bro-science mythology or vendor marketing fluff. What does the actual laboratory data say? And why does geography matter when we are talking about research models? Let us dig into this. Not from a "here is how to run a cycle" perspective, because that would be irresponsible and also against the spirit of what these compounds actually are. Instead, let us look at this from a research standpoint. What are scientists actually studying when they work with these compounds? What do the cell cultures and assay models reveal? And why does Dallas keep coming up in these conversation...

 If you're new to the world of research peptides, one of the first questions you'll probably ask is: how long is this actually going to take to get here? Whether you're planning a study timeline, waiting on a critical batch, or just trying to figure out if a vendor is worth the hassle, shipping speed matters. A lot. But here's the thing—peptide shipping isn't quite as straightforward as ordering a phone case off Amazon. There are variables at play that a lot of people don't think about until they're staring at a tracking number that hasn't updated in three days. So let's break this down. I've spent way too much time digging through vendor policies, reading forum posts, and comparing notes with other researchers. Here's what I've learned about how long it actually takes for research peptides to land on your doorstep, and what you can do to make the process smoother. I'll also throw in some practical stuff about Orion Peptides since the...

 Disclaimer: The products discussed in this post are for research purposes only and are not intended for human direct consumption. This is strictly an educational discussion about laboratory research compounds. I've been going down a rabbit hole lately on tesofensine, specifically how it fits into the broader picture of neuro-metabolic research. If you're anything like me, you've probably seen this compound pop up in discussions around appetite regulation, metabolic rate, and dopamine signaling, but a lot of the information floating around is either surface-level or buried in academic papers that most of us don't have the patience to parse through. So I figured I'd put together something comprehensive based on what I've been reading, and open it up for discussion. What Exactly Is Tesofensine? Tesofensine is a triple monoamine reuptake inhibitor, which is a fancy way of saying it blocks the reuptake of three key neurotransmitters: dopamine, norepinephrine, and se...

 I’ve been going down a research rabbit hole lately on something that doesn’t get nearly enough attention in the mainstream TRT and longevity circles: small-fiber neuropathy and the compounds being studied to address it. Specifically, I’ve been reading up on ARA-290, also known as cibinetide. If you’ve ever dealt with burning feet, unexplained nerve pain, or those weird tingling sensations that no doctor seems to take seriously, this might be worth your attention. Let’s talk about what this compound actually is, why New York has become an interesting hub for this kind of research, and how the models work. What Exactly Is Small-Fiber Neuropathy? Small-fiber neuropathy is one of those conditions that’s easy to dismiss until it happens to you. Unlike the large nerve fibers that control muscle strength and vibration sense, small fibers handle things like temperature perception, pain signaling, and autonomic functions. When they start to degrade, you get symptoms that don’t show up on s...

 Hey everyone, I've been seeing a lot of posts lately from people frustrated with their retatrutide results. Some are seeing dramatic weight loss, while others feel like they're injecting water for all the difference it's making. If you're in that second camp, this post is for you. Let's dig into what the clinical research actually says about individual response to retatrutide, why some people respond differently than others, and what you can realistically expect. The Hype vs. Reality Check First, let's acknowledge the elephant in the room. Retatrutide has generated massive buzz because the clinical trial data is genuinely impressive. In the TRIUMPH-1 phase 3 trial, participants on the 12mg dose lost an average of 28.3% of their body weight over 80 weeks, which is roughly 70 pounds . That's approaching bariatric surgery territory. But here's the thing about averages. They tell you what happened to a group of people. They don't tell you what will happ...

 Hey everyone, I've been lurking on this sub for a while now, and I've noticed one question that comes up constantly: "What is the starting dose?" Whether you're researching GLP-1 medications for weight management, exploring peptide protocols, or just trying to understand the landscape of metabolic health treatments, this question is absolutely critical. Get it wrong, and you're either wasting your time with subtherapeutic levels or signing yourself up for a rough ride of side effects. So let me break this down properly. I've spent months researching this stuff, talking to people who've been through it, and digging through clinical documentation. Here's everything you need to know about starting doses for the most common peptide-based treatments. Why Starting Doses Matter More Than You Think Before we get into specific numbers, let's talk about why this matters so much. Your body doesn't like surprises. When you introduce a new compound tha...